The scientific services company recorded third-quarter sales of $11.12 billion on the back of growth in its life sciences ...

Thermo Fisher (TMO) lifts 2025 outlook with strong sales and margin gains. Fair value estimate near $570 provides a limited ...

Thermo Fisher (TMO) stock gains as the company beats Street forecasts with its Q3 2025 earnings results thanks to all-around ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy right now. On October 20, ...

Thermo Fisher Scientific’s plan for growth is paying off as the biopharma service provider and supplier posted a sales bump ...

Adjusted EPS in the third quarter of 2025 were $5.79, versus $5.28 in the third quarter of 2024. Adjusted operating income ...

Thermo Fisher Scientific (NYSE:TMO) shares climbed 1.4% after the company posted third-quarter earnings that beat analyst ...

Thermo Fisher Scientific Inc (TMO) reports robust financial performance with a 5% revenue increase and upwardly revised 2025 ...

Thermo Fisher Scientific raised its annual profit and revenue forecasts on Wednesday, as the medical equipment maker expects robust demand for lab tools and benefits from its recent acquisitions to ...

Thermo Fisher Scientific reports Q3 2025 adjusted earnings of $5.79 per share, sales of $11.12 billion and raised its ...

In terms of liquidity and interest, the mean open interest for Thermo Fisher Scientific options trades today is 604.81 with a total volume of 20,341.00.

The initiative reflects the PPD business’ vision to promote sustainability throughout the clinical development ecosystem.